Stephanie Davis
Stock Analyst at Barclays
(0)
# 4806
Out of 5,249 analysts
159
Total ratings
33.33%
Success rate
-22.88%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OptimizeRx | Maintains: Equal-Weight | 11 5 | 5.39 | -7.24% | 3 | Nov 14, 2024 | |
Doximity | Maintains: Overweight | 52 75 | 55.7 | 34.65% | 5 | Nov 11, 2024 | |
LifeStance Health Gr | Maintains: Underweight | 6 7 | 7.99 | -12.39% | 2 | Nov 11, 2024 | |
GoodRx Holdings | Maintains: Overweight | 10 6 | 4.92 | 21.95% | 7 | Nov 11, 2024 | |
Evolent Health | Maintains: Overweight | 39 19 | 10.15 | 87.19% | 1 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 263 290 | 247.86 | 17% | 2 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 22.28 | 7.72% | 3 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 129.41 | 2.77% | 2 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 58 | 43.13 | 34.48% | 2 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 3.19 | -5.96% | 7 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 154 168 | 151.83 | 10.65% | 3 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | 1.11 | -32.43% | 3 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 6.89 | -27.43% | 10 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 213 249 | 244.59 | 1.8% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 37.88 | -36.64% | 1 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 14 | n/a | n/a | 6 | Feb 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 10 | n/a | n/a | 6 | Jan 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 27.26 | 6.38% | 11 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 11 | n/a | n/a | 10 | Jan 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 | 10.12 | 235.97% | 9 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 59 34 | 22.02 | 54.41% | 3 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 242 233 | 223.21 | 4.39% | 9 | Dec 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 17 | 5.78 | 194.12% | 10 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | n/a | n/a | 6 | Oct 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 76 | 104.67 | -27.39% | 5 | Jun 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 4 | n/a | n/a | 7 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 95 | n/a | n/a | 4 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 34 36 | n/a | n/a | 4 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 45 41 | 29.25 | 40.17% | 4 | Aug 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | n/a | n/a | 7 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 53 | n/a | n/a | 2 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 35 | n/a | n/a | 2 | Aug 10, 2020 |